Another RICOdiculous Decision
Drug & Device Law
JULY 24, 2023
2022) (many other cases recognize this problem with class actions). This time-tested type of evidence is mostly absent from the analysis in PATDC82 II – as in Neurontin , the only actual prescriber testimony belied plaintiffs’ position. E.g. , Laudato v. EQT Corp. , 4th 256, 260 (3d Cir. How could this happen?
Let's personalize your content